FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCardinal Health, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CAH
Cardinal Health, Inc. Stock AnalysisComprehensive stock analysis for Cardinal Health, Inc. (CAH) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCAH
CAH
Cardinal Health, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CAH
  1. Home
  2. Stocks
  3. Cardinal Health, Inc.

Cardinal Health, Inc.

🇺🇸CAH•NYSE

Cardinal Health, Inc.

🇺🇸CAH•NYSE
Market cap
$65.61B
Sentiment

Your view on CAH

Mkt Cap
$65.61B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cardinal Health, Inc.

Industry
Medical - Distribution
Sector
Healthcare
CEO
Jason M. Hollar
Headquarters
7000 Cardinal Place, Dublin, OH, US
Industry
Medical - Distribution
Sector
Healthcare
CEO
Jason M. Hollar
Headquarters
7000 Cardinal Place, Dublin, OH, US
Description

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.

The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals.

The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.

The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits.

The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Cardinal Health, Inc. from FRC's valuation model, read against the market price. CAH last traded at $283.85, 36.6× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Cardinal Health, Inc.. Starting points for Cardinal Health, Inc.: P/E 36.6, EPS $7.84, beta 0.52 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Cardinal Health, Inc.. Cardinal Health, Inc. paid $2.05 per share over the last year — a 0.7% yield at the current $283.85 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Cardinal Health, Inc.. Trailing twelve-month EPS for Cardinal Health, Inc. stands at $7.84. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$288.27

average of 11 firms, last 12 months

 

$288.27

Low $265.00

Median $290.00

High $321.00

 

Analyst Ratings

Buy13 firms, last 12 months
  • Strong Buy0
  • Buy12
  • Hold1
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimate$3.13$3.35$12.90$14.36
Low estimate$2.91$2.92$12.51$13.37
High estimate$3.62$3.52$12.97$14.82
No. of analysts7799
Year-ago EPS$2.63$3.17$7.23—
Growth+19.1%+5.8%+78.4%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimate$68.30B$63.59B$266.15B$281.95B
Low estimate$67.83B$62.92B$264.39B$275.13B
High estimate$68.76B$64.04B$268.20B$289.97B
No. of analysts771211
Year-ago revenue$65.44B$60.94B$254.25B—
Growth+4.4%+4.4%+4.7%—
Recent analyst actions15 rating and price-target changes, latest Nov 17, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Cardinal Health, Inc.. Cardinal Health, Inc. has reported as a listed company since 1983. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CAH17 companies · 8 funds
Compare CAH with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • CORCencora, Inc.Medical - Distribution$68.1B
  • HSICHenry Schein, Inc.Medical - Distribution$9.4B
  • MCKMcKesson CorporationMedical - Distribution$127.6B
  • SHPMYShanghai Pharmaceuticals Holding Co., LtdMedical - Distribution$5.2B
  • SHTDYSinopharm Group Co. Ltd.Medical - Distribution$8.8B
  • SIG.AXSigma Healthcare LimitedMedical - Distribution

More Medical - Distribution companies

  • MEPDFMediPal Holdings CorporationOTC$3.9B
  • NSVGFNass Valley Gateway Ltd.OTC$3M
  • PDRXPD-Rx Pharmaceuticals, Inc.OTC$6M
  • PGC.AXParagon Care LimitedASX
  • PHRXPharmagen, Inc.OTC$5,171
  • RDGTRidgetech Inc.NASDAQ$4M
  • SAEYYRedcare Pharmacy N.V.OTC$1.4B
  • SCRCQScripsAmerica, Inc.OTC$14,108
  • SECISector 10, Inc.OTC$31
  • SHPMFShanghai Pharmaceuticals Holding Co., LtdOTC$8.5B
  • SHPPFRedcare Pharmacy N.V.OTC$1.5B

ETFs holding Cardinal Health, Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.09%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.08%
  • VOVanguard Mid-Cap ETF$103.4B in assets0.56%
  • IVViShares Core SP 500 ETF$852.9B in assets0.10%
  • SPYState Street SPDR S&P 500 ETF Trust$818.5B in assets0.10%
  • VTVVanguard Value ETF$184.2B in assets0.21%
  • SEIVSEI Enhanced U.S. Large Cap Value Factor ETF$1.6B in assets2.90%
  • IYKiShares US Consumer Staples ETF$1.5B in assets2.77%

Largest holders first, then the funds most concentrated in CAH.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Cardinal Health, Inc., and how their positions are changing. At a $65.61B market value, institutional positions materially move Cardinal Health, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Cardinal Health, Inc. executives and directors. Shares of Cardinal Health, Inc. have traded between $114.60 and $208.32 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Cardinal Health, Inc.. Cardinal Health, Inc. is a $65.61B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Cardinal Health, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Cardinal Health, Inc.. Coverage tracks Cardinal Health, Inc. within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Cardinal Health, Inc.

CAH Analysis
Fair
Past5
Growth5
Health1
Profit1
Value1

News

Latest Market News